Induction of CD4CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT

International Archives of Allergy and Immunology

Volumn 153, Issue 1, 2010, Pages 19-26

  Wei, Wang ^a   Liu, Yongge ^a   Wang, Yonghong ^a   Zhao, Yuhong ^a   He, Jianxin ^a   Li, Xiang ^a   Shen, Kunling ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CD4+CD25+Foxp3+; Children; House dust mite; IFN ; IL 10; IL 4; Regulatory T cells; Specific immunotherapy; TGF 1

Indexed keywords

ALUTARD; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLERGIC ASTHMA; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; UPREGULATION; ANIMAL; ASTHMA; CD4+ T LYMPHOCYTE; DESENSITIZATION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; MOUSE; PYROGLYPHIDAE;

ANIMALS; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; PYROGLYPHIDAE; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 77950045651     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000301575     Document Type: Article

References (26)

1. Singh V, Agrewala JN: Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells. BMC Immunol 2006; 7: 17.
2. Wegmann M: Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Rev Mol Diagn 2009; 9: 85-100.
3. Akdis M, Akdis CA: Mechanisms of allergen- specific immunotherapy. J Allergy Clin Immunol 2007; 119: 780-791.
4. Trautmann A, Schmid-Grendelmeier P, Kruger K, Crameri R, Akdis M, Akkaya A, Brocker EB, Blaser K, Akdis CA: T cells and eosinophils cooperate in the induction of bronchial epithelial apoptosis in asthma. J Allergy Clin Immunol 2002; 109: 329-337.
5. Ozdemir C, Akdis M, Akdis CA: T regulatory cells and their counterparts: masters of immune regulation. Clin Exp Allergy 2009; 39: 626-639.
6. Feuerer M, Hill JA, Mathis D, Benoist C: Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 2009; 10: 689-695.
7. Jutel M, Akdis CA: T-cell regulatory mechanisms in specific immunotherapy. Chem Immunol Allergy 2008; 94: 158-177.
8. Akdis CA, Blaser K, Akdis M: Mechanisms of allergen-specific immunotherapy. Chem Immunol Allergy 2006; 91: 195-203.
9. E. Alvarez, Cuesta, J. Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E: Standards for practical allergen-specific immunotherapy. Allergy 2006; 61: 1-20.
10. Jutel M, Akdis M, Blaser K, Akdis CA: Mechanisms of allergen specific immunotherapy T cell tolerance and more. Allergy 2006; 61: 796-807. (Pubitemid 43893981)
11. Martinez-Gomez JM, Johansen P, Rose H, Steiner M, Senti G, Rhvner C, Crameri R, Kundig TM: Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy 2009; 64: 172-178.
12. James N, Francis, Stephen J, Till, and Stephen R, Durtham SR: Induction of IL-10 + CD4 + CD25 + T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111: 1255-1261.
13. Gardner LM, Thien FC, Douglass JA, Rolland JM, O'Hehir RE: Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4 + CD25 + interleukin-10 + T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004; 34: 1209-1219.
14. Akdis M, Akdis CA: Mechanisms of allergen- specific immunotherapy. J Allergy Clin Immunol 2007;119: 780-789.
15. Schiopu A, Wood KJ: Regulatory T cells: hypes and limitations. Curr Opin Organ Transplant 2008; 13: 333-338.
16. Ajduk J, Marinic I, Aberle N, Rabatic S, Gagro A: Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children. Ann Allergy Asthma Immunol 2008; 100: 314-322.
17. Lin YL, Shieh CC, Wang JY: The functional insufficiency of human CD4 + CD25 high Tregulatory cells in allergic asthma is subjected to TNF-α modulation. Allergy 2008; 63: 67-74.
18. Jutel M, Akdis CA: T-cell regulatory mechanisms in specific immunotherapy. Chem Immunol Allergy 2008; 94: 158-177.
19. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J: Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27: 1131-1139.
20. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K: Role of interleukin-10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
21. Heddle RJ, Brown SG: Venom immunotherapy: worth the time and trouble. Clin Exp Allergy 2009; 39: 774-776.
22. Burastero SE, Mistrello G, Falagiani P, Paolucci C, Breda D, Roncarolo D, Zanotta S, Monasterolo G, Rossi RE: Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin-10 production. Ann Allergy Asthma Immunol 2008; 100: 343-350.
23. Wachholz P, Nouri-Aria KT, Wilson DR, Walker SM, Verhoef A, Till SJ, Durham SR: Grass pollen immunotherapy for hayfever is associated with increases in local nasal mucosal but not peripheral Th1/Th2 ratios. Immunology 2002; 105: 56-62.
24. Ozyilmaz E, Cznbakan S, Capan N, Erturk A, Gulhan M: Correlation of plasma transforming growth factor beta 1 with asthma control test. Allergy Asthma Proc 2009; 30: 35-40.
25. Taytor AW: Review of the activation of TGFbeta in immunity. J Leukoc Biol 2009; 85: 29-33.
26. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ: Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121: 1120-1125.